Point-of-care test developed for tumor marker in human saliva based on lanthanide nanoprobes

Salivary assay, emerging as a non-invasive alternative to blood assay in clinic analysis, holds great promise for early-stage cancer diagnostics with advantages of low cost, easy collection and facile processing. Therefore, point-of-care (POC) detection of tumor markers in the saliva is urgently demanded. Continue reading at Physorg